- call +1-201-465-4211
- email sales@mrinsights.biz
The respiratory therapy area consists of indications that affect the respiratory system in different ways, such as the scarring of lung tissue, and excessive production of mucus in the airways, thereby decreasing lung function. Some of the key indications in this therapy area include asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and idiopathic pulmonary fibrosis (IPF). The causes of respiratory disorders vary significantly across each indication, and include factors such as environment, occupation, genetic predisposition and aging.
Scope of the Report:
The worldwide market for Breathing Disorders & Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Breathing Disorders & Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
AstraZeneca
Boehringer
GSK
Merck
Roche
Novartis
Abbott
Actavis
Afferent Pharmaceuticals
Alere
Almirall
Amgen
AptarGroup
Astellas
Aurobindo
Axis-Shield
Baxter
Bayer
Biogen
Biotest
Bristol-Myers Squibb
Chiesi Farmaceutici
Cipla
Cytos
Dainippon Sumitomo
Dr. Reddy's Laboratories
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Asthma
COPD
Allergic rhinitis
Pulmonary hypertension
Cystic fibrosis
Idiopathic pulmonary fibrosis
Market Segment by Applications, can be divided into
Hospital
Clinics
Other
There are 15 Chapters to deeply display the global Breathing Disorders & Treatment market.
Chapter 1, to describe Breathing Disorders & Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Breathing Disorders & Treatment, with sales, revenue, and price of Breathing Disorders & Treatment, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Breathing Disorders & Treatment, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Breathing Disorders & Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Breathing Disorders & Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Breathing Disorders & Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Asthma
1.2.2 COPD
1.2.3 Allergic rhinitis
1.2.4 Pulmonary hypertension
1.2.5 Cystic fibrosis
1.2.6 Idiopathic pulmonary fibrosis
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinics
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Breathing Disorders & Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Boehringer
2.2.1 Business Overview
2.2.2 Breathing Disorders & Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boehringer Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 GSK
2.3.1 Business Overview
2.3.2 Breathing Disorders & Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GSK Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Breathing Disorders & Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Roche
2.5.1 Business Overview
2.5.2 Breathing Disorders & Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Breathing Disorders & Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Abbott
2.7.1 Business Overview
2.7.2 Breathing Disorders & Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Abbott Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Actavis
2.8.1 Business Overview
2.8.2 Breathing Disorders & Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Actavis Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Afferent Pharmaceuticals
2.9.1 Business Overview
2.9.2 Breathing Disorders & Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Afferent Pharmaceuticals Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Alere
2.10.1 Business Overview
2.10.2 Breathing Disorders & Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Alere Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Almirall
2.11.1 Business Overview
2.11.2 Breathing Disorders & Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Almirall Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Amgen
2.12.1 Business Overview
2.12.2 Breathing Disorders & Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Amgen Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 AptarGroup
2.13.1 Business Overview
2.13.2 Breathing Disorders & Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 AptarGroup Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Astellas
2.14.1 Business Overview
2.14.2 Breathing Disorders & Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Astellas Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Aurobindo
2.15.1 Business Overview
2.15.2 Breathing Disorders & Treatment Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Aurobindo Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Axis-Shield
2.16.1 Business Overview
2.16.2 Breathing Disorders & Treatment Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Axis-Shield Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Baxter
2.17.1 Business Overview
2.17.2 Breathing Disorders & Treatment Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Baxter Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Bayer
2.18.1 Business Overview
2.18.2 Breathing Disorders & Treatment Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Bayer Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Biogen
2.19.1 Business Overview
2.19.2 Breathing Disorders & Treatment Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Biogen Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Biotest
2.20.1 Business Overview
2.20.2 Breathing Disorders & Treatment Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Biotest Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Bristol-Myers Squibb
2.21.1 Business Overview
2.2.2 Breathing Disorders & Treatment Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Bristol-Myers Squibb Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22 Chiesi Farmaceutici
2.22.1 Business Overview
2.22.2 Breathing Disorders & Treatment Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Chiesi Farmaceutici Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.23 Cipla
2.23.1 Business Overview
2.23.2 Breathing Disorders & Treatment Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Cipla Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.24 Cytos
2.24.1 Business Overview
2.24.2 Breathing Disorders & Treatment Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Cytos Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.25 Dainippon Sumitomo
2.25.1 Business Overview
2.25.2 Breathing Disorders & Treatment Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Dainippon Sumitomo Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.26 Dr. Reddy's Laboratories
2.26.1 Business Overview
2.26.2 Breathing Disorders & Treatment Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 Dr. Reddy's Laboratories Breathing Disorders & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Breathing Disorders & Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Breathing Disorders & Treatment Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Breathing Disorders & Treatment Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Breathing Disorders & Treatment Manufacturer Market Share in 2017
3.3.2 Top 6 Breathing Disorders & Treatment Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Breathing Disorders & Treatment Market Analysis by Regions
4.1 Global Breathing Disorders & Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Breathing Disorders & Treatment Sales and Market Share by Regions (2013-2018)
4.1.2 Global Breathing Disorders & Treatment Revenue and Market Share by Regions (2013-2018)
4.2 North America Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
4.3 Europe Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
4.5 South America Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
5 North America Breathing Disorders & Treatment by Countries
5.1 North America Breathing Disorders & Treatment Sales, Revenue and Market Share by Countries
5.1.1 North America Breathing Disorders & Treatment Sales and Market Share by Countries (2013-2018)
5.1.2 North America Breathing Disorders & Treatment Revenue and Market Share by Countries (2013-2018)
5.2 United States Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
5.3 Canada Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
5.4 Mexico Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
6 Europe Breathing Disorders & Treatment by Countries
6.1 Europe Breathing Disorders & Treatment Sales, Revenue and Market Share by Countries
6.1.1 Europe Breathing Disorders & Treatment Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Breathing Disorders & Treatment Revenue and Market Share by Countries (2013-2018)
6.2 Germany Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
6.3 UK Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
6.4 France Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
6.5 Russia Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
6.6 Italy Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
7 Asia-Pacific Breathing Disorders & Treatment by Countries
7.1 Asia-Pacific Breathing Disorders & Treatment Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Breathing Disorders & Treatment Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Breathing Disorders & Treatment Revenue and Market Share by Countries (2013-2018)
7.2 China Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
7.3 Japan Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
7.4 Korea Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
7.5 India Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
8 South America Breathing Disorders & Treatment by Countries
8.1 South America Breathing Disorders & Treatment Sales, Revenue and Market Share by Countries
8.1.1 South America Breathing Disorders & Treatment Sales and Market Share by Countries (2013-2018)
8.1.2 South America Breathing Disorders & Treatment Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
8.3 Argentina Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
8.4 Colombia Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
9 Middle East and Africa Breathing Disorders & Treatment by Countries
9.1 Middle East and Africa Breathing Disorders & Treatment Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Breathing Disorders & Treatment Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Breathing Disorders & Treatment Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
9.3 UAE Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
9.4 Egypt Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
9.5 Nigeria Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
9.6 South Africa Breathing Disorders & Treatment Sales and Growth Rate (2013-2018)
10 Global Breathing Disorders & Treatment Market Segment by Type
10.1 Global Breathing Disorders & Treatment Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Breathing Disorders & Treatment Sales and Market Share by Type (2013-2018)
10.1.2 Global Breathing Disorders & Treatment Revenue and Market Share by Type (2013-2018)
10.2 Asthma Sales Growth and Price
10.2.1 Global Asthma Sales Growth (2013-2018)
10.2.2 Global Asthma Price (2013-2018)
10.3 COPD Sales Growth and Price
10.3.1 Global COPD Sales Growth (2013-2018)
10.3.2 Global COPD Price (2013-2018)
10.4 Allergic rhinitis Sales Growth and Price
10.4.1 Global Allergic rhinitis Sales Growth (2013-2018)
10.4.2 Global Allergic rhinitis Price (2013-2018)
10.5 Pulmonary hypertension Sales Growth and Price
10.5.1 Global Pulmonary hypertension Sales Growth (2013-2018)
10.5.2 Global Pulmonary hypertension Price (2013-2018)
10.6 Cystic fibrosis Sales Growth and Price
10.6.1 Global Cystic fibrosis Sales Growth (2013-2018)
10.6.2 Global Cystic fibrosis Price (2013-2018)
10.7 Idiopathic pulmonary fibrosis Sales Growth and Price
10.7.1 Global Idiopathic pulmonary fibrosis Sales Growth (2013-2018)
10.7.2 Global Idiopathic pulmonary fibrosis Price (2013-2018)
11 Global Breathing Disorders & Treatment Market Segment by Application
11.1 Global Breathing Disorders & Treatment Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 Breathing Disorders & Treatment Market Forecast (2018-2023)
12.1 Global Breathing Disorders & Treatment Sales, Revenue and Growth Rate (2018-2023)
12.2 Breathing Disorders & Treatment Market Forecast by Regions (2018-2023)
12.2.1 North America Breathing Disorders & Treatment Market Forecast (2018-2023)
12.2.2 Europe Breathing Disorders & Treatment Market Forecast (2018-2023)
12.2.3 Asia-Pacific Breathing Disorders & Treatment Market Forecast (2018-2023)
12.2.4 South America Breathing Disorders & Treatment Market Forecast (2018-2023)
12.2.5 Middle East and Africa Breathing Disorders & Treatment Market Forecast (2018-2023)
12.3 Breathing Disorders & Treatment Market Forecast by Type (2018-2023)
12.3.1 Global Breathing Disorders & Treatment Sales Forecast by Type (2018-2023)
12.3.2 Global Breathing Disorders & Treatment Market Share Forecast by Type (2018-2023)
12.4 Breathing Disorders & Treatment Market Forecast by Application (2018-2023)
12.4.1 Global Breathing Disorders & Treatment Sales Forecast by Application (2018-2023)
12.4.2 Global Breathing Disorders & Treatment Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Breathing Disorders & Treatment Picture
Table Product Specifications of Breathing Disorders & Treatment
Figure Global Sales Market Share of Breathing Disorders & Tre
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
